Apimeds Pharmaceuticals US, Inc.
SEC CIK 1894525 · APUS · last insider filing 2025-11-21
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| O'Donnell Carol A | Director | filed 2025 - 2025 |
| Kogan Elona Esq. | Director | filed 2025 - 2025 |
| Weintraub Bennett | Director | filed 2025 - 2025 |
| Yoon Hankil | Director | filed 2025 - 2025 |
| Koo Jakap | Director | filed 2025 - 2025 |
| Emerson Erik C. | Director · Chief Executive Officer | filed 2025 - 2025 |
| Kim Christopher | Director · Chairman and CMO | filed 2025 - 2025 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Corrao Mark | Chief Financial Officer | filed 2025 - 2025 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.